StockData

Generate Biomedicines, Inc. (GENB) stock

GENBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.84−0.65 (-6.20%)

Close on Nov 17, 2026Market cap $1.26BP/E –Yield –

Generate Biomedicines total assets

Total assets on the balance sheet at the end of each period.

Generate Biomedicines's total assets was $515.89M at Sep 30, 2026. For fiscal 2025 it was $330.18M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$330.18M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$515.89M–
Q2 FY2026Jun 30, 2026$561.69M–
Q1 FY2026Mar 31, 2026$625.74M–
Q4 FY2025Dec 31, 2025$330.18M–

More Generate Biomedicines figures

See a number that looks wrong?